ReviewTherapeutic advances in medical oncology2019
Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States.
Emily M Miller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it